AmorChem is a venture capital fund investing in promising life sciences projects from Québec Universities and Research Centers. AmorChem’s innovative business model involves investing in early-stage research projects and bringing them to preclinical proof of concept in a semi-virtual fashion. The fund aims to generate profits in one of two ways:
- through the sale of projects that have reached the proof of concept stage to major pharmaceutical or biotechnology companies;
- through the start-up of companies based on the combination of several projects financed by AmorChem.
|For whom ?||Québec Universities and Research Centers|
|How much ?||Up to $ 1M|
|What ?||Venture Fund|
|For what ?||Life sciences projects aimed at commercialization from Québec universities and research centers|